tirzepatide march 2025 What The FDA's Changes Mean for Providers in FDA Declares End to Tirzepatide

[DOI] [PMC free article] [PubMed] [Google Scholar] 40.Lucey M., Pickford P., Bitsi S., Minnion J., Ungewiss J., Schoeneberg K., Rutter G.A., Bloom S.R., Tomas A., Jones B

2011;105(suppl 2):S66S69

Serious symptoms such as a seizure, severe allergic reaction, chest pain, hallucinations, extreme confusion, or manic symptoms need urgent medical care

doi: 10.3389/fphar.2023.1228722 Received 25 May 2023 Accepted 26 June 2023 Published 04 July 2023 Volume 14 - 2023 Edited by Aliyu Muhammad, Ahmadu Bello University, Nigeria Reviewed by Abdurrahman Pharmacy Yusuf, Federal University of Technology Minna, Nigeria Kang-Hoon Kim, Monell Chemical Senses Center, United States Updates Copyright 2023 Wu, Xia, Guo, Wang, Dong, Lu and Yuan